Clinical Trials

Lung Neoplasms

NCT06122610 2026-03-19

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

Phase 1 Recruiting

10 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT03258593 2026-03-17

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

Phase 1 Completed

15 enrolled 21 charts

Phase NA Not yet recruiting

Urinary Bladder Neoplasms, Carcinoma in Situ

NCT07478757 2026-03-17

Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized Controlled Trial in Hong Kong

15,000 enrolled

Lung Neoplasms

NCT07462247 2026-03-12

Establishment of Image Database for Early Upper Gastrointestinal Cancer, Precancerous Lesions, and Precancerous Conditions

500 enrolled

Gastrointestinal Neoplasms

NCT03151564 2026-03-05

Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing Techniques

146 enrolled

Colonic Neoplasms, Digestive System Diseases, Colorectal Neoplasms

NCT04857528 2026-03-04

Detecting HPV DNA in Anal and Cervical Cancers

GastrointestinalGynecologic

20 enrolled

Anus Neoplasms, Uterine Cervical Neoplasms

NCT03789240 2026-03-03

Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma

Phase 2 Active not recruiting

33 enrolled 17 charts

Phase 1 Not yet recruiting

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

NCT07417488 2026-02-27

GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas

18 enrolled

Colorectal Neoplasms

NCT03388619 2026-02-23

Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy

Phase 1 Completed

30 enrolled 16 charts

Prostatic Neoplasms

NCT07416825 2026-02-18

Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19

Phase NA Completed

23 enrolled

Phase 1/2 Active not recruiting

Esophageal Neoplasms

NCT04432597 2026-02-17

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

39 enrolled

GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms

NCT04504331 2026-02-12

Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer

Phase 1 Terminated

4 enrolled 11 charts

Breast Neoplasms

NCT03458520 2026-02-09

Pediatric PET/MR Image Registry

Phase NA Not yet recruiting

100 enrolled

LymphoidSarcoma

Lymphoma, Osteosarcoma

NCT07383454 2026-02-03

Lung Cancer Screening in Population Who Had Never Smoked

2,500 enrolled

Carcinoma, Non-Small-Cell Lung, Disease, Lung Neoplasms, Small Cell Lung Carcinoma

NCT02297672 2026-02-02

PBSI

75 enrolled

Breast Neoplasms

NCT03697577 2026-01-23

CDK and Body Composition Study

30 enrolled

Breast Neoplasms

NCT04294641 2026-01-23

Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease

Other hematologic neoplasm

10 enrolled 15 charts

Bronchiolitis Obliterans Syndrome, Hematologic Neoplasms

NCT06865677 2026-01-21

Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas

Phase 2 Terminated

2 enrolled 7 charts

Recurrence

NCT06199713 2026-01-20

Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients

24 enrolled

Dermatologic

Melanoma

NCT03388632 2025-12-18

Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers

Phase 1 Completed

31 enrolled 20 charts

Other solid neoplasm

Metastatic Solid Tumors

NCT05035407 2025-12-02

T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers

Phase 1 Terminated

36 enrolled 7 charts

Carcinoma, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT07250347 2025-11-26

AI-Assisted Detection and Staging of Gastric Cancer Using Contrast-Enhanced CT

8,000 enrolled

Stomach Neoplasms

NCT06566209 2025-10-15

FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis

Other hematologic neoplasm

30 enrolled

Myocarditis, Hematologic Neoplasms

NCT05557487 2025-09-10

TRIO

6,618 enrolled

Lung Neoplasms, Smoking

NCT00924027 2025-09-05

A Study of Patients Receiving High-Dose Rate Brachytherapy

GastrointestinalGenitourinaryGynecologic

43 enrolled 13 charts

Biliary Tract Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT05009979 2025-08-28

18F-DCFPyL PET/CT in Hepatocellular Carcinoma

Phase 2 Terminated

8 enrolled 14 charts

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05012098 2025-08-08

Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).

11 enrolled 14 charts

CNS

Nose Neoplasms, Esthesioneuroblastoma, Olfactory

NCT02769962 2025-07-28

Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer

Phase 1/2 Completed

45 enrolled 30 charts

GenitourinaryThoracic

Carcinoma, Transitional Cell, Lung Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT07062172 2025-07-14

Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer

Phase NA Recruiting

1,753 enrolled

Lung Neoplasms

NCT00001337 2025-06-22

Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

348 enrolled 15 charts

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

NCT00001379 2025-06-19

Treatment and Natural History Study of Lymphomatoid Granulomatosis

94 enrolled 20 charts

Lymphoma, Lymphoma, Non-Hodgkin, Lymphomatoid Granulomatosis, Lymphoproliferative Disorders, Epstein-Barr Virus Infections

NCT03315871 2025-06-19

Combination Immunotherapy in Biochemically Recurrent Prostate Cancer

40 enrolled 14 charts

Prostatic Neoplasms

NCT03554473 2025-05-09

M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers

Phase 1/2 Completed

37 enrolled 19 charts

Lung Neoplasms, Carcinoma, Small Cell, Small Cell Lung Carcinoma

NCT03053960 2025-04-30

Helical CT, PET/CT, MRI, and CBCT Alone or in Combination in Predicting Jaw Invasion in Patients With Oral Cancer

Terminated

8 enrolled 5 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT06944587 2025-04-25

NORPACT-3

400 enrolled

Locally Advanced Pancreatic Cancer

NCT06943742 2025-04-24

Non-Helium Magnetoencephalography in Pediatric Brain Tumors

100 enrolled

Pediatric Brain Tumor

NCT03038568 2025-04-23

Assessing How Normal Variations in CT Scanning Affects Its Interpretation

Active not recruiting

169 enrolled

Colorectal Cancer Metastatic

NCT06933758 2025-04-18

Temple Health Chest Initiative (THCI 2.0)

1,000 enrolled

Pulmonary Disease, Chronic Obstructive

NCT03824535 2025-04-09

18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules

15 enrolled 7 charts

Smoking Cessation, Multiple Pulmonary Nodules

NCT06331130 2025-03-12

MIO

510 enrolled

Gynecologic

Ovarian Neoplasms

NCT06869694 2025-03-11

CTIDGC

300 enrolled

Stomach Neoplasms

NCT06867172 2025-03-10

SPACE

66 enrolled

Platelet Glycoprotein IV Deficiency, Adenocarcinoma, Cysts, Fatty Liver, Neoplasms, Pancreatic Cyst

NCT03142802 2025-02-10

Low-Dose CT - Stage I Testicular Cancer

251 enrolled

Testicular Neoplasms

NCT06082492 2025-02-05

NVALT31-PET

Phase NA Recruiting

690 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06793657 2025-01-27

Poppy Seed Use in Gastroenteric Fistula Diagnosis

Phase EARLY_PHASE1 Completed

100 enrolled

Fistula

NCT04510311 2025-01-10

Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors

32 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT06626178 2024-10-03

ARIA

Phase NA Recruiting

2,840 enrolled

Lung Neoplasms

NCT04933617 2024-07-09

Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell Lymphomas

Phase 1 Terminated

8 enrolled 17 charts